including individuals living with pain, family members of people living with pain, health care providers, representatives of the pharmaceutical industry, and individuals representing pain advocacy groups. The committee found this input to be highly informative for its deliberations. Agendas for the four meetings are presented in Boxes A-1 through A-4.
In addition to testimony at these meetings, the committee solicited public input on topics relevant to its charge through its website. More than 2,000 individuals provided written testimony. A summary of these comments can be found in Appendix B.
The committee commissioned a paper on the economic burden of pain. The specific aim of this work was to provide an assessment of the economic and societal costs of pain and pain care, including such topics as health care expenditures, out-of-pocket costs, costs related to lost work or unemployment, and other individual-level impacts (see Appendix C).